History

May 1, 2007
May 1, 2007

DR Healthcare foundation

Headquarters in Barcelona (Spain) and start of its activities.

March 1, 2009
March 1, 2009

Presentation of the migraine-histamine hypothesis

Presentation of the hypothesis linking histamine to migraine processes, among the...

November 1, 2009
November 1, 2009

MigraDAO1

Start of the MigraDAO1 study at the University of Barcelona.

May 1, 2010
May 1, 2010

First evidence of "DAO-migraine"

Presentation of the results of the MigraDAO1 study at the International Migraine Day, held in...

March 1, 2012
March 1, 2012

Vienna, Annual Congress of Neurology

Awarded 2nd Prize at the 6th World Congress on Controversies in Neurology (CONy).

July 1, 2012
July 1, 2012

Barcelona College of Doctors

DR Healthcare has the support of the medical community.

March 1, 2013
March 1, 2013

Migraine- DAO

Presentation of the MigraDAO2 study results at the INFARMA Congress.

March 1, 2013
March 1, 2013

Leipzig, Germany

Publication of the study linking migraine, due to DAO Deficiency, with gastrointestinal symptoms.

September 1, 2013
September 1, 2013

Vienna, XXI World Congress of Neurology (WCN)

Presentation of the results of the MigraDAO2.

June 1, 2014
June 1, 2014

Jerusalem

Presentation of the study linking migraine, due to DAO Deficiency, with gastrointestinal symptoms.

October 1, 2015
October 1, 2015

Havana, Cuba

Presentation of the ADHD study-International Congress of Psychiatry.

April 1, 2016
April 1, 2016

Probiotics- DAO

Beginning of studies of probiotic micro-organisms with DAO activity.

October 1, 2016
October 1, 2016

New clinical trial study.

DAO treatment in patients with chronic non-allergic rhinitis.

June 1, 2017
June 1, 2017

New publication on migraine

Low serum levels of Diamine Oxidase (DAO) in migraine patients.

January 1, 2018
January 1, 2018

Clinical Nutrition Research

Publication of the DAO-migraine studies in the journal Clinical Nutrition Research.

January 2, 2018
January 2, 2018

European Commission

The active ingredient DAO is authorized by the European Commission according to Regulation 2018/1023, as...

January 3, 2018
January 3, 2018

Vegetable DAO

Beginning of the first research on plant-derived DAO.

June 1, 2018
June 1, 2018

Presentation of DAO Vegetal studies

Presentation of DAO Vegetal studies.

February 1, 2019
February 1, 2019

First animal DAO production plant

Inauguration of the first DAO production plant of animal origin in Tarragona.

March 1, 2019
March 1, 2019

Presentation of new DAO smart capsules

Presentation of new DAO smart capsules

April 1, 2019
April 1, 2019

DAO Genetic Study

Presentation of the first study of the ACO1 gene coding for DAO synthesis.

May 1, 2019
May 1, 2019

DAO Portfolio

Presentation of the new family of products with DAO enzyme.

June 1, 2020
June 1, 2020

European Commission

European Commission approves new pharmaceutical forms (tablets and capsules) of DAO enzyme.

May 26, 2021
May 26, 2021

AB Biotek Acquires Spanish Biomedical DR Healthcare

Respective leaders in fermentation science and DAO-based medical nutrition join together to focus on innovative...

November 4, 2021
November 4, 2021

International Congress of DAO Deficiency 2021

You are invited to map a new future in managing DAO Deficiency attending the International...

May 1, 2022
May 1, 2022

Vegetable DAO production plant

Inauguration of the DAO Vegetal production plant in Tarragona.

November 17, 2022
November 17, 2022

2nd International Congress on DAO Deficiency

DR Healthcare, together with the International Society for DAO Deficiency, is organizing the second...

May, 2007
May, 2007

DR Healthcare foundation

Headquarters in Barcelona (Spain) and start of its activities.

March, 2009
March, 2009

Presentation of the migraine-histamine hypothesis

Presentation of the hypothesis linking histamine to migraine processes, among the...

November, 2009
November, 2009

MigraDAO1

Start of the MigraDAO1 study at the University of Barcelona.

May, 2010
May, 2010

First evidence of "DAO-migraine"

Presentation of the results of the MigraDAO1 study at the International Migraine Day, held in...

March, 2012
March, 2012

Vienna, Annual Congress of Neurology

Awarded 2nd Prize at the 6th World Congress on Controversies in Neurology (CONy).

July, 2012
July, 2012

Barcelona College of Doctors

DR Healthcare has the support of the medical community.

March, 2013
March, 2013

Migraine- DAO

Presentation of the MigraDAO2 study results at the INFARMA Congress.

March, 2013
March, 2013

Leipzig, Germany

Publication of the study linking migraine, due to DAO Deficiency, with gastrointestinal symptoms.

September, 2013
September, 2013

Vienna, XXI World Congress of Neurology (WCN)

Presentation of the results of the MigraDAO2.

June, 2014
June, 2014

Jerusalem

Presentation of the study linking migraine, due to DAO Deficiency, with gastrointestinal symptoms.

October, 2015
October, 2015

Havana, Cuba

Presentation of the ADHD study-International Congress of Psychiatry.

April, 2016
April, 2016

Probiotics- DAO

Beginning of studies of probiotic micro-organisms with DAO activity.

October, 2016
October, 2016

New clinical trial study.

DAO treatment in patients with chronic non-allergic rhinitis.

June, 2017
June, 2017

New publication on migraine

Low serum levels of Diamine Oxidase (DAO) in migraine patients.

January, 2018
January, 2018

Clinical Nutrition Research

Publication of the DAO-migraine studies in the journal Clinical Nutrition Research.

January, 2018
January, 2018

European Commission

The active ingredient DAO is authorized by the European Commission according to Regulation 2018/1023, as...

January, 2018
January, 2018

Vegetable DAO

Beginning of the first research on plant-derived DAO.

June, 2018
June, 2018

Presentation of DAO Vegetal studies

Presentation of DAO Vegetal studies.

February, 2019
February, 2019

First animal DAO production plant

Inauguration of the first DAO production plant of animal origin in Tarragona.

March, 2019
March, 2019

Presentation of new DAO smart capsules

Presentation of new DAO smart capsules

April, 2019
April, 2019

DAO Genetic Study

Presentation of the first study of the ACO1 gene coding for DAO synthesis.

May, 2019
May, 2019

DAO Portfolio

Presentation of the new family of products with DAO enzyme.

June, 2020
June, 2020

European Commission

European Commission approves new pharmaceutical forms (tablets and capsules) of DAO enzyme.

May, 2021
May, 2021

AB Biotek Acquires Spanish Biomedical DR Healthcare

Respective leaders in fermentation science and DAO-based medical nutrition join together to focus on innovative...

November, 2021
November, 2021

International Congress of DAO Deficiency 2021

You are invited to map a new future in managing DAO Deficiency attending the International...

May, 2022
May, 2022

Vegetable DAO production plant

Inauguration of the DAO Vegetal production plant in Tarragona.

November, 2022
November, 2022

2nd International Congress on DAO Deficiency

DR Healthcare, together with the International Society for DAO Deficiency, is organizing the second...